Unsung immune cells take over when covid antibodies wane

The study showing they wane quickly in patients with mild disease dealt a blow to hopes that antibodies will provide some lasting form of immunity

Marthe Fourcade, Jason Gale( with inputs from Bloomberg)
Updated23 Jul 2020, 07:34 PM IST
Photo: Bloomberg
Photo: Bloomberg

Antibodies have become a familiar word in the pandemic era, perhaps suggesting they’re the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.

AstraZeneca Plc, Pfizer Inc. and partner BioNTech SE, as well as China’s CanSino Biologics Inc. all hailed the presence of these white blood cells in vaccine recipients as a sign their experimental shots show promise.

Thrust into focus by recent studies, T cells are a reminder that the body’s defenses rely on more than one weapon, and that much of the immune response to Covid-19 is still a mystery -- especially after researchers revealed that the more lauded antibodies lack staying power.

“Antibodies are only a very small part of the picture,” said Paul Griffin, an associate professor of medicine at the University of Queensland in Brisbane, who is leading clinical studies in Australia of two potential Covid-19 vaccines. But “we’re really not there yet in terms of fully understanding” people’s immunity to the new coronavirus.

As the pandemic took the world by storm, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders -- because eliciting them is the basis for most successful vaccines. The immune proteins are also easier to measure than T cells and can be used to gauge prior infection.

The study showing they wane quickly in patients with mild disease dealt a blow to hopes that antibodies will provide some lasting form of immunity.

Unsung warriors

T cells, by contrast, are able to kill virus-infected cells, remember past diseases for decades, and rouse fresh antibody soldiers long after the first have left the battlefield. People infected with another coronavirus that was responsible for the SARS epidemic in 2003, for example, still have a T-cell response to the disease 17 years later.

That suggests T cells may still, at least hypothetically, be ready to protect SARS survivors against the infection almost two decades later, and might bolster their defense against Covid-19.

“Antibodies wane after a certain period of time,” said Thomas Schinecker, who heads the diagnostics unit of Swiss drugmaker Roche Holding AG. “This doesn’t mean that there is no immunity, it just means that potentially the memory cells, T cells and others, will then be triggered to respond much better the second time so that you don’t have any severe response.”

One study found that some patients with no symptoms of Covid-19 had T-cells that recognized the virus -- even when they had no detectable antibodies. Another pointed to a level of immunity in people who never encountered the pathogen, possibly because of exposure to one or more of the coronaviruses that cause the common cold.

Balancing act

More research is needed to determine whether pre-existing T cells that cross-react with the SARS-CoV-2 virus may explain why some Covid patients are barely affected while others get very sick and even die. What’s clear is that a balance of both antibodies and T cells is necessary for optimal defense, according to Griffin.

Corey Smith, head of translational and human immunology at the QIMR Berghofer Medical Research Institute in Brisbane, says the findings about antibodies’ short duration don’t mean immunity wanes completely, precisely because of T cells.

So-called helper T cells, as well as memory T and B cells are able to prime antibodies to respond to a subsequent infection before it causes severe symptoms, said Smith, who is studying the immune response to the SARS-CoV-2 virus.

The virus, like other coronaviruses that cause the common cold, may have a way of evading antibodies, leading to reinfection, Smith said. “But there’s enough cellular immunity to put a dampener on any severe symptoms.”

If could be that T cells are what ultimately subdue and blunt the pandemic virus that’s killed more than 600,000 people in less than seven months.

“If we can’t eradicate it, does it end up as a kind of a circulating virus, another cold virus?” Smith said. “I’m not sure, but it’s interesting.”


Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:23 Jul 2020, 07:34 PM IST
Business NewsScienceHealthUnsung immune cells take over when covid antibodies wane

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    150.75
    03:10 PM | 7 NOV 2024
    -2.85 (-1.86%)

    Bharat Electronics share price

    300.40
    03:10 PM | 7 NOV 2024
    -1.45 (-0.48%)

    Bank Of Baroda share price

    262.85
    03:10 PM | 7 NOV 2024
    0.25 (0.1%)

    Indian Oil Corporation share price

    144.25
    03:10 PM | 7 NOV 2024
    -0.4 (-0.28%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Apollo Hospitals Enterprise share price

    7,436.00
    03:01 PM | 7 NOV 2024
    466.15 (6.69%)

    Welspun Corp share price

    797.30
    03:00 PM | 7 NOV 2024
    23.85 (3.08%)

    Federal Bank share price

    206.40
    03:01 PM | 7 NOV 2024
    1.6 (0.78%)

    City Union Bank share price

    180.80
    03:01 PM | 7 NOV 2024
    1.3 (0.72%)
    More from 52 Week High

    Adani Energy Solutions share price

    971.55
    03:01 PM | 7 NOV 2024
    -103.75 (-9.65%)

    Hindalco Industries share price

    648.00
    03:01 PM | 7 NOV 2024
    -60.25 (-8.51%)

    Trent share price

    6,476.80
    03:01 PM | 7 NOV 2024
    -476.25 (-6.85%)

    Glenmark Pharmaceuticals share price

    1,658.95
    03:01 PM | 7 NOV 2024
    -110 (-6.22%)
    More from Top Losers

    Swan Energy share price

    539.95
    03:01 PM | 7 NOV 2024
    43.4 (8.74%)

    KEC International share price

    1,045.45
    03:01 PM | 7 NOV 2024
    69.95 (7.17%)

    Apollo Hospitals Enterprise share price

    7,436.00
    03:01 PM | 7 NOV 2024
    466.15 (6.69%)

    JSW Energy share price

    715.00
    03:01 PM | 7 NOV 2024
    32.75 (4.8%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      78,575.00-1,790.00
      Chennai
      78,581.00-1,790.00
      Delhi
      78,733.00-1,790.00
      Kolkata
      78,585.00-1,790.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      100.80/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in Science

        HomeMarketsPremiumInstant LoanMint Shorts